The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.
- First select the CSR Section, then a Table/Figure from that section.
- Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.
To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.
Download and Print: Download Printer-friendly PDF Download data
Table 9.23
All Lymphoid Neoplasms With Detailed Hodgkin Lymphoma Subtypesa
SEERb Incidence Rates and Annual Percent Change by Age at Diagnosis
All Races, Males, 2008-2017
| Site | All Ages | Ages 0-19 | Ages 20-64 | Ages 65+ | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rate | Count | APC | Rate | Count | APC | Rate | Count | APC | Rate | Count | APC | |
| Lymphoid Neoplasm | 46.2 | 258,947 | -0.6* | 7.0 | 10,934 | 0.4 | 29.4 | 111,596 | -0.7* | 213.2 | 136,417 | -0.6 |
| 1 Hodgkin Lymphoma | 3.1 | 17,536 | -1.7* | 1.3 | 2,081 | -0.5 | 3.6 | 12,370 | -1.6* | 4.7 | 3,085 | -3.0* |
| 1(a) Classical Hodgkin lymphoma | 2.8 | 15,991 | -2.3* | 1.1 | 1,813 | -1.4* | 3.2 | 11,286 | -2.2* | 4.4 | 2,892 | -3.2* |
| 1(a)1. Lymphocyte-rich/mixed cellularity/ lymphocyte-depleted | 0.5 | 2,938 | -6.4* | 0.2 | 271 | -3.9 | 0.6 | 2,043 | -5.8* | 1.0 | 624 | -8.7* |
| 1(a)1.1 Lymphocyte-rich | 0.1 | 609 | -3.7* | 0.0 | 58 | -2.0 | 0.1 | 450 | -3.9* | 0.2 | 101 | -3.0 |
| 1(a)1.2 Mixed cellularity | 0.4 | 2,152 | -6.5* | 0.1 | 207 | -3.5 | 0.4 | 1,482 | -6.0* | 0.7 | 463 | -8.6* |
| 1(a)1.3 Lymphocyte-depleted | 0.0 | 177 | -13.6* | - | - | - | 0.0 | 111 | -9.2 | 0.1 | 60 | -16.5* |
| 1(a)2. Nodular sclerosis | 1.4 | 8,064 | -3.6* | 0.8 | 1,190 | -2.1 | 1.7 | 5,938 | -3.4* | 1.4 | 936 | -6.5* |
| 1(a)3. Classical Hodgkin lymphoma, NOSc | 0.9 | 4,989 | 2.3* | 0.2 | 352 | 4.5* | 0.9 | 3,305 | 2.3* | 2.1 | 1,332 | 1.8 |
| 1(b) Nodular lymphocyte predominant Hodgkin Lymphoma | 0.3 | 1,545 | 4.5* | 0.2 | 268 | 5.6 | 0.3 | 1,084 | 5.1* | 0.3 | 193 | 0.6 |
| 2 Non-Hodgkin lymphoma | 42.1 | 235,884 | -0.4 | 5.6 | 8,696 | 0.4 | 25.3 | 97,214 | -0.5* | 203.1 | 129,974 | -0.5 |
| 3 Composite Hodgkin lymphoma and Non-Hodgkin lymphoma | 0.1 | 521 | 23.9* | - | - | - | 0.1 | 247 | 19.5* | 0.4 | 259 | 27.0* |
| 4 Lymphoid neoplasm, NOSc | 0.9 | 5,006 | -6.1* | 0.1 | 142 | 8.4 | 0.5 | 1,765 | -5.9* | 5.0 | 3,099 | -6.8* |
Footnotes:
The APC is the Annual Percent Change over the time interval.
a Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, Jack A, Cozen W, Maynadié M, Spinelli JJ, Costantini AS, Rüdiger T, Scarpa A, Zheng T, Weisenburger DD. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007;110:695-708.
b SEER 21 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey, Georgia excluding ATL/RG, Idaho, New York and Massachusetts).
c NOS = Not otherwise specified.
* The APC is significantly different from zero (p<.05).
- Statistic not shown. Rate based on less than 16 cases for the time interval. Trend based on less than 10 cases for at least one year within the time interval.
Page Navigation: << Previous Next >>
The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.